The U.S. Food and Drug Administration is in the process of issuing a draft enforcement policy on cannabis-derived compounds, including cannabidiol (CBD). That draft is currently at the White House for review.
Depending on how that policy ends up, FDA could issue more warning letters to pet product companies using CBD in their formulations.
Read More